Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Turoctocog_alfa> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Turoctocog_alfa abstract "Turoctocog alfa (trade name NovoEight) is a recombinant antihemophilic factor VIII used for the treatment of and prophylaxis of bleeding patients with haemophilia A. It is marketed by Novo Nordisk. It was first launched in Germany in January 2014 and has been approved in the US, EU and Japan.".
- Turoctocog_alfa wikiPageID "41872607".
- Turoctocog_alfa wikiPageLength "5316".
- Turoctocog_alfa wikiPageOutDegree "11".
- Turoctocog_alfa wikiPageRevisionID "618140490".
- Turoctocog_alfa wikiPageWikiLink Category:Recombinant_proteins.
- Turoctocog_alfa wikiPageWikiLink Chinese_hamster_ovary_cell.
- Turoctocog_alfa wikiPageWikiLink Factor_VIII.
- Turoctocog_alfa wikiPageWikiLink Factor_X.
- Turoctocog_alfa wikiPageWikiLink Fever.
- Turoctocog_alfa wikiPageWikiLink Haemophilia_A.
- Turoctocog_alfa wikiPageWikiLink Novo_Nordisk.
- Turoctocog_alfa wikiPageWikiLink Recombinant_factor_VIIa.
- Turoctocog_alfa wikiPageWikiLink Thrombin.
- Turoctocog_alfa wikiPageWikiLink Von_Willebrand_disease.
- Turoctocog_alfa wikiPageWikiLinkText "Turoctocog alfa".
- Turoctocog_alfa wikiPageWikiLinkText "turoctocog alfa".
- Turoctocog_alfa atcPrefix "B02".
- Turoctocog_alfa atcSuffix "BD02".
- Turoctocog_alfa legalStatus "Rx-only".
- Turoctocog_alfa tradename "NovoEight".
- Turoctocog_alfa wikiPageUsesTemplate Template:Antihemorrhagics.
- Turoctocog_alfa wikiPageUsesTemplate Template:Drugs.com.
- Turoctocog_alfa wikiPageUsesTemplate Template:Infobox_drug.
- Turoctocog_alfa wikiPageUsesTemplate Template:Reflist.
- Turoctocog_alfa subject Category:Recombinant_proteins.
- Turoctocog_alfa hypernym VIII.
- Turoctocog_alfa type ChemicalSubstance.
- Turoctocog_alfa type Drug.
- Turoctocog_alfa type ChemicalObject.
- Turoctocog_alfa type Thing.
- Turoctocog_alfa type Q8386.
- Turoctocog_alfa comment "Turoctocog alfa (trade name NovoEight) is a recombinant antihemophilic factor VIII used for the treatment of and prophylaxis of bleeding patients with haemophilia A. It is marketed by Novo Nordisk. It was first launched in Germany in January 2014 and has been approved in the US, EU and Japan.".
- Turoctocog_alfa label "Turoctocog alfa".
- Turoctocog_alfa sameAs Q22075842.
- Turoctocog_alfa sameAs m.0_lld0m.
- Turoctocog_alfa sameAs Q22075842.
- Turoctocog_alfa wasDerivedFrom Turoctocog_alfa?oldid=618140490.
- Turoctocog_alfa isPrimaryTopicOf Turoctocog_alfa.